MHRA Drug Safety Update January 2022

A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 15 Issue 6 January 2022) has been published and includes articles on:

  • Brolucizumab (Beovu▼): risk of intraocular inflammation and retinal vascular occlusion increased with short dosing intervals
  • Paclitaxel formulations (conventional and nab-paclitaxel): caution required due to potential for medication error
  • COVID-19 vaccines and medicines: updates for January 2021
  • Letters and medicine recalls sent to healthcare professionals in December 2021

To see the latest MHRA Drug Safety Updates in full, visit the website

Discover how we are working to improve the outlook for community pharmacy at an event near you.

Click Here